<DOC>
	<DOCNO>NCT00839306</DOCNO>
	<brief_summary>The purpose study compare efficacy rabeprazole extend release 50 mg ( daily ) versus ranitidine 150 mg ( twice daily ) maintenance complete healing subject heal erosive gastroesophageal reflux disease ( eGERD ) .</brief_summary>
	<brief_title>Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg Maintenance Healed Erosive Gastroesophageal Reflux Disease ( GERD )</brief_title>
	<detailed_description>This multicenter , randomize , double-blind , double-dummy , parallel-group study . Subjects meet eligibility criterion randomly assign 1 2 treatment group , rabeprazole extend release 50 mg ( daily ) ranitidine 150 mg ( twice daily ) . Please note study duplicate E3810-G000-305 ; separate study conduct along -305 .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<mesh_term>Ranitidine</mesh_term>
	<mesh_term>Ranitidine bismuth citrate</mesh_term>
	<criteria>KEY INCLUSION CRITERIA : 1 . Prior completion Study E3810G000302 303 . Subjects need heal erosive esophagitis ( absence esophageal mucosal break erosion ) confirm EGD sustain resolution heartburn Visit 4 5 Study E3810G000302 303 . KEY EXCLUSION CRITERIA : 1 . Esophageal motility disorder ( achalasia , scleroderma , esophageal spasm ) . 2 . Barrett 's esophagus esophageal stricture . 3 . Use prescription nonprescription proton pump inhibitor ( PPIs ) , histamine receptor antagonist ( H2RA ) , antacid , sucralfate , misoprostol , prokinetics drug significant anticholinergic effect throughout study . 4 . Subjects require chronic use nonsteroidal antiinflammatory drug ( NSAIDs ) , oral steroid ( &gt; = 20 mg/day prednisone equivalent ) , aspirin ( &gt; ; 325 mg/day ) . 5 . Significant hepatic , renal , respiratory , endocrine , hematologic , neurologic , psychiatric , cardiovascular system abnormality would likely interfere conduct study , interpretation study result , health subject study . 6 . Any condition would make subject , opinion Investigator Sponsor , unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Gastroesophageal</keyword>
	<keyword>Reflux</keyword>
	<keyword>Disease</keyword>
	<keyword>GERD</keyword>
</DOC>